|
South Africa to Lead Pharmaceutical Market in Middle East and Africa
By Shushmul Maheshwari
RNCOS E-Services Pvt. Ltd.
Email: press@rncos.com
http://www.rncos.com/
Thursday - September 24, 2009
Category: Investment, Biotech
Rapid changes in regulatory environment, high investments and increasing prevalence of several lifestyle-related diseases have led growth in the South African pharmaceutical market in an effective manner. All these factors have also resulted in the rapid advancements of the country's healthcare infrastructure. Our new research study "Middle East and Africa Pharma Sector Forecast to 2012" anticipates that pharma market in South Africa will grow at a CAGR of over 8% to generate revenue of around US$ 4.7 Billion by 2012, ranking it one of the highest growing pharma markets in the overall region.
We have done extensive research on pharma market in the Middle East and Africa region in order to identify various developments and trends undergoing in key markets. According to our study, South Africa is the leading country in the region in terms of revenue generation and will retain its leading position in near future also. Various factors, such as ageing population, increasing prevalence of lifestyle-related diseases, have strongly boosted the growth of pharmaceutical market. Moreover, the government is promoting the sector by making investments in active research and development of drugs.
We have observed that most of the country level markets are dependent on import. More than half of the drugs are imported in the region from the American and European countries and because of this, drug prices in the region are very high. For this, the governments of respective countries are trying to improve their domestic production level. Moreover, regulations are being changed in several countries to restrict excessive import of drugs.
Our study "Middle East and Africa Pharma Sector Forecast to 2012" analyzes key markets and their segments to give information about the pharma industry in the Middle East and Africa region. According to our industry experts, several steps should be taken by governments to make easy the approval system in order to promote investment in dedicated research and development.
The report also provides detailed analysis of factors fueling growth in the pharma market. Besides, the report contains qualitative statistics of various industrial segments for thorough evaluation of the past and present market trends.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM218.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
Published at Investorideas.com Financial Article Feed : http://www.investorideas.com/RSS/feeds/II-Art.xml
About InvestorIdeas.com: One of the first online investor resources providing in-depth information on renewable energy, greentech and water sectors.
Become an Investorideas.com Member
Gain Exclusive Insight on Leading Sectors, Global Trends, and Insider Trading Ideas, News, Articles, renewable energy and water stocks directory.
Learn more: http://www.investorideas.com/membership
Sign up for free newsletter, stock and sector news alerts at Investorideas.com
click here: http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer: The views and opinions expressed in the research published are those of the individual companies and writers and not necessarily those of Investorideas.comŽ, or any of the industry sector portals . At the time of publication, writers may hold positions in the stocks or companies mentioned.
Investorideas.comŽ or any of the industry sector portals cannot assure accuracy of the research presented. Investors are encouraged to research and verify facts and under no circumstances is Investorideas.comŽ endorsing the content as a recommendation to buy or sell stock.
|
